SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
NEPH

Nephros Inc (NEPH)

NASDAQ: NEPH · USD
Healthcare · Medical Instruments & Supplies
$2.61-$0.23 (-8.10%)
 
Market cap
$28.4M
Insider Score
Analyst consensus
Market Cap$28.37M-47.0%
Revenue (ttm)$21.58M
Net Income$1.91M
EPS$0.17
Shares Out10.87M
PE Ratio15.35
Forward PE11.86
Dividendn/a
Ex-Dividend Daten/a
Volume50,233
Open$2.79
Previous Close$2.84
Day's Range$2.61 - $2.85
52-Week Range$2.61 - $6.42
Beta1.75
AnalystsBuy
Price Target$6.08(+133.08%)
Earnings DateNov 5, 2026
-8.10% (1D)
No price history available.

About NEPH

Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water; reduce biofilm and scale build-up; and remove cysts, particulates, and lead from water systems. It markets its products to food service and hospitality sectors including quick-service restaurants, convenience stores, and restaurants. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

Address
380 Lackawanna Place, South Orange, NJ, 07079, United States
Market Cap
28 million
Employees
36
Industrial Classification
Medical Instruments & Supplies

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$0
Bought
$22.07K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

1 Day
-8.10%
5 Days
-14.43%
1 Month
-25.85%
6 Months
-24.78%
1 Year
-46.95%

$NEPH stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in NEPH holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by NEPH's directors and management

Net Shares Purchased by Insiders−8k−4k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

NEPH Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New NEPH patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to NEPH from public contracts

Source: USAspending.gov

Bull Case vs Bear Case

AI-generated from NEPH’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
44.09
Analyst Ratings
32% of score
85
News & Sentiment
20% of score
72

News check: Record customer sites and double-digit growth in Q3 2026 earnings, plus analyst upgrade recommendation suggests bullish momentum despite recent weakness.

Recent Insider Activity

Buys
2
Sells
0
Buy Value
$22.07K
Distinct Buyers
1

Insider Score Trend Over Time

-2.5 since Nov 19
0255075100Nov 19 — Insider Score 80.5Nov 20 — Insider Score 79.3Nov 21 — Insider Score 78.3Nov 22 — Insider Score 78.0Nov 19Nov 20Nov 22

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.